ProCE Banner Activity

Overview of EGFR-Mutated NSCLC and Pharmacology of EGFR TKIs

Slideset Download
Download this slideset to review the landscape of EGFR mutations in advanced NSCLC and the pharmacology of EGFR tyrosine kinase inhibitors used in this setting.

Released: March 25, 2019

Expiration: March 23, 2020

No longer available for credit.

Share

Faculty

Val Robb

Val Robb, RN

Clinical Nurse III
UCSF Positive Health Program
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Val Robb, RN

Clinical Nurse III
UCSF Positive Health Program
San Francisco, California